160 related articles for article (PubMed ID: 24628251)
1. Carotid dosimetry for T1 glottic cancer radiotherapy.
Garcez K; Lim CC; Whitehurst P; Thomson D; Ho KF; Lowe M; Sykes A; Lee LW; Yap B; Slevin N
Br J Radiol; 2014 Jun; 87(1038):20130754. PubMed ID: 24628251
[TBL] [Abstract][Full Text] [Related]
2. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
Sert F; Karakoyun-Çelik O; Esassolak MA
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
[TBL] [Abstract][Full Text] [Related]
3. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
Rosenthal DI; Fuller CD; Barker JL; Mason B; Garcia JA; Lewin JS; Holsinger FC; Stasney CR; Frank SJ; Schwartz DL; Morrison WH; Garden AS; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):455-61. PubMed ID: 19679406
[TBL] [Abstract][Full Text] [Related]
4. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer.
Atalar B; Gungor G; Caglar H; Aydin G; Yapici B; Ozyar E
Tumori; 2012; 98(3):331-6. PubMed ID: 22825509
[TBL] [Abstract][Full Text] [Related]
5. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma.
Inal A; Duman E; Ozkan EE
J Cancer Res Ther; 2020; 16(3):485-493. PubMed ID: 32719255
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
7. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada.
Jackson LD; Groome PA; Schulze K; O'Sullivan B; Irish JC; Dixon PF; Eapen LJ; Gulavita SP; Hammond JA; Hodson DI; Mackenzie RG; Bissett RJ; Schneider KM; Warde PR; Mackillop WJ
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):266-79. PubMed ID: 12924458
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
10. Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
Gujral DM; Long M; Roe JW; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):42-50. PubMed ID: 27815039
[TBL] [Abstract][Full Text] [Related]
11. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
12. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
13. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord.
Chera BS; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1380-5. PubMed ID: 19942356
[TBL] [Abstract][Full Text] [Related]
14. Comparison of external beam treatment techniques for T1-2, N0, M0 glottic cancers.
Camingue P; Christian R; Ng D; Williams P; Amin M; Roniger DL
Med Dosim; 2012; 37(2):221-4. PubMed ID: 22366494
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early-stage glottic cancer.
Matthiesen C; Herman Tde L; Singh H; Mascia A; Confer M; Simpson H; Higby C; Arain A; Keole S; Herman T; Bogardus C; Zhao YD; Ahmad S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):221-8. PubMed ID: 25146003
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients.
Sanguineti G; Pellini R; Vidiri A; Marzi S; D'Urso P; Terrenato I; Farneti A; Fuga V; Ungania S; Landoni V
Tumori; 2021 Dec; 107(6):514-524. PubMed ID: 33821713
[TBL] [Abstract][Full Text] [Related]
19. Accelerated three-dimensional conformal radiotherapy for early-stage glottic cancer in reducing dose to the internal carotid artery and pharyngeal constrictor muscles.
Tomizawa K; Motegi A; Oyoshi H; Fujisawa T; Zenda S; Zhou Y; Nakamura M; Hirata H; Hojo H; Kageyama SI; Hirotaki K; Matsuura K; Akimoto T
Head Neck; 2024 Feb; 46(2):239-248. PubMed ID: 37933710
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
Samuels MA; Freedman LM; Elsayyad N
Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]